跳至主要内容
临床试验/KCT0003234
KCT0003234招募中未知

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the finger of systemic sclerosis patients

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients were eligible
  • 1. if they were aged 18 or older
  • 2. Patients show no more response or no progression to medical treatment (Calcium channel inhibitor, PDE4 inhibitor, endothelin receptor antagonist) and patients who have adverse effects to medical treatment.

排除标准

  • Exclusion criteria
  • -new vasodilators or immunosuppressive therapy for systemic sclerosis in the 3 months prior to enrolment
  • -surgical contraindication
  • - clinical or radiological signs of digital infection
  • -positive status for HIV, hepatitis B or C or syphilis, pregnancy and BMI <17kg/m2

研究者

发起方
The Catholic University of Korea, Seoul St. Mary&#39;s Hospital

相似试验

Safety and efficacy of treatment of autologous... | 临床试验